Trials / Unknown
UnknownNCT06246331
Evaluation of the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled Injection
An Observational Study on the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled Injection Administered for Reversal of Neuromuscular Blockade in Patients Receiving General Anesthesia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- Hanlim Pharm. Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluate clinical efficacy and safety in adult patients administered BriTurn injection or BrisTurn Prefilled injection for reversal of neuromuscular blockade induced by Rocuronium or Vecuronium.
Detailed description
This study evaluate clinical efficacy and safety in adult patients administered BriTurn injection or BrisTurn Prefilled injection for reversal of neuromuscular blockade induced by Rocuronium or Vecuronium. * Efficacy: Time (minutes) for Train-Of-Four (TOF) ratio to reach 0.9 (90%) * Safety: whether bradycardia and resulting cardiac arrest occur or whether bronchospasm occurs
Conditions
Timeline
- Start date
- 2023-07-21
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2024-02-07
- Last updated
- 2024-02-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06246331. Inclusion in this directory is not an endorsement.